Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
252.73
-3.23 (-1.26%)
Nov 20, 2026, 4:00 PM EST - Market closed
Ascendis Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $330 → $335 | Buy | Maintains | $330 → $335 | +32.55% | Nov 16, 2026 |
| Barclays | Barclays | Buy Maintains $329 → $341 | Buy | Maintains | $329 → $341 | +34.93% | Nov 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $290 | Buy | Maintains | $290 | +14.75% | Nov 13, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $326 | Buy | Reiterates | $326 | +28.99% | Nov 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $304 | Buy | Reiterates | $304 | +20.29% | Nov 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $273 → $302 | Buy | Maintains | $273 → $302 | +19.50% | Nov 13, 2026 |
| Wedbush | Wedbush | Buy Reiterates $327 → $346 | Buy | Reiterates | $327 → $346 | +36.90% | Nov 13, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $326 → $356 | Buy | Maintains | $326 → $356 | +40.86% | Nov 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.